Login / Signup

ZnPP-laden nanoparticles improve glucose homeostasis and chronic inflammation during obesity.

Wanbao YangMeenakshi AroraHye Won HanWen JiangDa Mi KimWeiqi AiQuan PanM N V Ravi KumarWesley A BrashearYuxiang SunShaodong Guo
Published in: British journal of pharmacology (2024)
These findings indicate that ZnPP-laden nanoparticles are potential therapeutic agents for treating T2DM.
Keyphrases
  • metabolic syndrome
  • insulin resistance
  • oxidative stress
  • type diabetes
  • weight loss
  • weight gain
  • blood glucose
  • skeletal muscle
  • adipose tissue
  • glycemic control
  • physical activity
  • blood pressure